CANCER LETT 润色咨询

CANCER LETTERS

出版年份:1975 年文章数:4498 投稿命中率: 开通期刊会员,数据随心看

出版周期:Biweekly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2022-11-26 ms6000001778887566 来自上海

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤生物学;tumorigenesis
    经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2022-03-23 spark6016

    偏重的研究方向:乳腺癌;免疫;肿瘤
    经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞

    28

    展开28条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2023-09-19 SYHenry 来自上海

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:妇科肿瘤;肿瘤分子生物学
    经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2021-07-02 ms5000001336362850

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。
    我真的是迷惑了。。。这个是什么个情况。

    15

    展开15条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2020-12-10 gf296144988

    各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position).

    20

    展开20条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2023-02-25 1231eb1dm07(暂无昵称) 来自广东省

    偏重的研究方向:肿瘤
    经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2019-09-11 1213078bm33(暂无昵称)

    请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙151DLST783 2019-09-08 发表::
    审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。
    151DLST783 2019-09-08 00:00:00 发表:
    审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。

    151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2023-07-09 ms2000002007484521 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤;肿瘤分子生物学
    经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2023-05-14 小小搬运工 来自广西

    偏重的研究方向:肿瘤
    经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2102819, encodeId=0a7121028191d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学;tumorigenesis<br>经验分享:一审1个多月,二审1周多,能够接收真的是好运,总体来说还是挺快的,实验室目前投4中1,整体来说对工作量有一定要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67a06524515, createdName=ms6000001778887566, createdTime=Sat Nov 26 23:04:22 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1205099, encodeId=51311205099f9, content=偏重的研究方向:乳腺癌;免疫;肿瘤<br>经验分享:2022.1.27投稿 2022.1.29 Under Review 2022.2.9 Require reviewer completed 2022.2.23一审意见大修 2022.3.15修回 2022.3.16接受 2022.3.17 Proof 2022.3.21 Pubmed 根据审稿人意见判断,送审三个审稿人,一个直接接受,一个小修一个大修。全程很效率,还无版面费!大赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=28, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201127/906b6b3a7769460d8216fa26688ca054/cbcc155e55564b408b53ab48f948da2b.jpg, createdBy=92552308769, createdName=spark6016, createdTime=Wed Mar 23 04:20:07 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158469, encodeId=e76f21584697a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇科肿瘤;肿瘤分子生物学<br>经验分享:2023.2.19 submitted to journal 2023.2.20 under review 2023.3.27 required reviews completed 2023.4.26 revision completed 2023.5.19 accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/26/b7263d9347cb9d00357e375e4ea4170b.jpg, createdBy=b8842038045, createdName=SYHenry, createdTime=Tue Sep 19 13:16:42 CST 2023, time=2023-09-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=978911, encodeId=fb6f9e8911c6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:6.18 第一次 submit,一直是submitted to journal 状态 6.23 要求改cover letter 格式,然后就直接Decision in process, 然后这个状态持续一周之后 6.29 就收到修回的邮件,Major revision, 提到的邮件中reviewer comments 只有让我们送语言润色和修改文章格式, 全程没有提改实验什么的。修回时间一个月。 <br>我真的是迷惑了。。。这个是什么个情况。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee975452828, createdName=ms5000001336362850, createdTime=Fri Jul 02 10:04:42 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906694, encodeId=d02890669423, content=各位大神,请问这个cover letter 是有什么格式要求么?求解答 2. The Cover Letter must be on Institution Letterhead and it must be complete with all information (Department, Laboratory, phone number, email, academic title, position). , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=797281934, createdName=gf296144988, createdTime=Thu Dec 10 13:55:04 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116418, encodeId=b2e421164180f, content=偏重的研究方向:肿瘤<br>经验分享:昨天中午投的,晚上收到邮件说要更改审稿人,更改完后收到了三封分配编辑的邮件,分别是主编、副编辑和编辑部发的,有没有大佬知道这是啥情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=428e2384755, createdName=1231eb1dm07(暂无昵称), createdTime=Sat Feb 25 14:28:19 CST 2023, time=2023-02-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=576201, encodeId=85d15e620194, content=请问你在投稿后有没有收到一封邮件说Your submission has been assigned to an Editorial board member who is an expert.收到多久后送外审的,已经收到这封邮件10天了,还是with editor是不是不太妙<span class="quote">151DLST783 2019-09-08 发表::<br>审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span><span class="quote">151DLST783 2019-09-08 00:00:00 发表:<br>审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。</span>, beContent=151DLST783 2019-09-08 发表:: 审稿时间:约1个月 审稿时间较快,编辑效率很高,投过去4天后送审,1审1个月左右,修稿时间较短,只给了一个月,返修回去半个月接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ce52235129, createdName=1213078bm33(暂无昵称), createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147195, encodeId=388e214e19513, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤;肿瘤分子生物学<br>经验分享:投了一篇公共数据生信结合mIHC实验验证的文章,估计希望有点不大,但也是抱着试试的心态。只要求能送审就算成功了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a68567048, createdName=ms2000002007484521, createdTime=Sun Jul 09 23:13:52 CST 2023, time=2023-07-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133721, encodeId=6db92133e21b0, content=偏重的研究方向:肿瘤<br>经验分享:cover letter要求多,要带上单位的logo,内容也有要求,想的注意一下 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca645447198, createdName=小小搬运工, createdTime=Sun May 14 09:11:47 CST 2023, time=2023-05-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=896686, encodeId=393c8966862c, content=投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Nov 03 18:23:16 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2020-11-03 darktempler

    投稿后内没外审就decision in process ,应该是拒稿可,关键是拒稿就快一点,拖了好几天了也不给邮件,我都没法再去投别的杂志,唉!

    6

    展开6条回复
共500条页码: 4/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分